ATE160178T1 - Verfahren und diagnostische kits unter verwendung von säuger-stresspromotoren zur bestimmung der toxizität einer verbindung - Google Patents

Verfahren und diagnostische kits unter verwendung von säuger-stresspromotoren zur bestimmung der toxizität einer verbindung

Info

Publication number
ATE160178T1
ATE160178T1 AT94907826T AT94907826T ATE160178T1 AT E160178 T1 ATE160178 T1 AT E160178T1 AT 94907826 T AT94907826 T AT 94907826T AT 94907826 T AT94907826 T AT 94907826T AT E160178 T1 ATE160178 T1 AT E160178T1
Authority
AT
Austria
Prior art keywords
stress
methods
diagnostic kits
toxic
compound
Prior art date
Application number
AT94907826T
Other languages
English (en)
Inventor
Spencer B Farr
Marque D Todd
Original Assignee
Harvard College
Xenometrix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21734317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE160178(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Harvard College, Xenometrix Inc filed Critical Harvard College
Application granted granted Critical
Publication of ATE160178T1 publication Critical patent/ATE160178T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
AT94907826T 1993-01-21 1994-01-21 Verfahren und diagnostische kits unter verwendung von säuger-stresspromotoren zur bestimmung der toxizität einer verbindung ATE160178T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US889693A 1993-01-21 1993-01-21

Publications (1)

Publication Number Publication Date
ATE160178T1 true ATE160178T1 (de) 1997-11-15

Family

ID=21734317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94907826T ATE160178T1 (de) 1993-01-21 1994-01-21 Verfahren und diagnostische kits unter verwendung von säuger-stresspromotoren zur bestimmung der toxizität einer verbindung

Country Status (12)

Country Link
US (3) US5811231A (de)
EP (1) EP0680517B2 (de)
JP (1) JP3509100B2 (de)
AT (1) ATE160178T1 (de)
AU (1) AU692434B2 (de)
CA (1) CA2154265C (de)
DE (1) DE69406772T3 (de)
DK (1) DK0680517T4 (de)
ES (1) ES2111289T5 (de)
GR (1) GR3026129T3 (de)
HK (1) HK1004920A1 (de)
WO (1) WO1994017208A1 (de)

Families Citing this family (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1004920A1 (en) * 1993-01-21 1998-12-11 President And Fellows Of Harvard College Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound
EP0759170B1 (de) * 1993-09-10 2008-07-09 The Trustees Of Columbia University In The City Of New York Verwendung von grünem fluoreszenzprotein
GB9420735D0 (en) * 1994-10-14 1994-11-30 Karobio Ab Reporter cell line
GB9424497D0 (en) * 1994-12-05 1995-01-25 Karobio Ab Reporter cell line
US6387651B1 (en) 1995-04-12 2002-05-14 Biolog, Inc. Comparative phenotype analysis of two or more microorganisms using a plurality of substrates within a microwell device
US5777888A (en) * 1995-08-09 1998-07-07 Regents Of The University Of California Systems for generating and analyzing stimulus-response output signal matrices
US5569588A (en) * 1995-08-09 1996-10-29 The Regents Of The University Of California Methods for drug screening
US6326140B1 (en) 1995-08-09 2001-12-04 Regents Of The University Of California Systems for generating and analyzing stimulus-response output signal matrices
GB9526509D0 (en) * 1995-12-23 1996-02-28 Univ Dundee Gene control
US6110671A (en) * 1996-04-04 2000-08-29 The United States Of America As Represented By The Secretary Of The Army Method of measuring tumor suppressor gene p53
US5928888A (en) * 1996-09-26 1999-07-27 Aurora Biosciences Corporation Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities
US6165709A (en) 1997-02-28 2000-12-26 Fred Hutchinson Cancer Research Center Methods for drug target screening
IL131336A0 (en) * 1997-02-28 2001-01-28 Du Pont A method for identifying the site of action of xenobiotic chemicals
GB9706414D0 (en) * 1997-03-27 1997-05-14 Univ Manchester Detection of DNA damage
US7031843B1 (en) * 1997-09-23 2006-04-18 Gene Logic Inc. Computer methods and systems for displaying information relating to gene expression data
WO1999016903A1 (en) * 1997-09-29 1999-04-08 Hsp Research Institute, Inc. Method for screening heat shock protein expression induction regulators
CA2310621A1 (en) * 1997-11-20 1999-06-03 Smithkline Beecham Corporation Methods for identifying the toxic/pathologic effect of environmental stimuli on gene transcription
CA2321931A1 (en) * 1998-03-06 1999-09-10 E.I. Du Pont De Nemours And Company Methods for identifying polycationic, peptide-like compounds with antibacterial activity
US5965352A (en) * 1998-05-08 1999-10-12 Rosetta Inpharmatics, Inc. Methods for identifying pathways of drug action
KR20010052341A (ko) * 1998-05-12 2001-06-25 로제타 인파마틱스 인코포레이티드 유전자 발현 분석을 위한 정량 방법, 시스템, 장치
US6132969A (en) * 1998-06-19 2000-10-17 Rosetta Inpharmatics, Inc. Methods for testing biological network models
US6501003B1 (en) 1998-07-08 2002-12-31 Wisconsin Alumni Research Foundation Transgentic mouse expressing green fluorescent protein in glial cells
US20030105044A1 (en) * 2001-10-17 2003-06-05 Isis Pharmaceuticals Inc. Antisense modulation of matrix metalloproteinase 1 expression
US6593084B2 (en) 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
US6203987B1 (en) 1998-10-27 2001-03-20 Rosetta Inpharmatics, Inc. Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns
US6950752B1 (en) 1998-10-27 2005-09-27 Rosetta Inpharmatics Llc Methods for removing artifact from biological profiles
US6468476B1 (en) * 1998-10-27 2002-10-22 Rosetta Inpharmatics, Inc. Methods for using-co-regulated genesets to enhance detection and classification of gene expression patterns
US6801859B1 (en) 1998-12-23 2004-10-05 Rosetta Inpharmatics Llc Methods of characterizing drug activities using consensus profiles
US6453241B1 (en) * 1998-12-23 2002-09-17 Rosetta Inpharmatics, Inc. Method and system for analyzing biological response signal data
US6370478B1 (en) 1998-12-28 2002-04-09 Rosetta Inpharmatics, Inc. Methods for drug interaction prediction using biological response profiles
US6222093B1 (en) 1998-12-28 2001-04-24 Rosetta Inpharmatics, Inc. Methods for determining therapeutic index from gene expression profiles
AU4186600A (en) * 1999-03-31 2000-10-16 Rosetta Inpharmatics, Inc. Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferation drugs
DE60030796T2 (de) 1999-04-14 2007-09-13 Sumitomo Chemical Co., Ltd. Zelle zur Bestimmung der Fähigkeit die Aktivität eines Liganden-abhängigen Transkriptionskontrollfaktors zu kontrollieren
CA2370749A1 (en) 1999-04-20 2000-10-26 Target Discovery, Inc. Polypeptide fingerprinting methods, metabolic profiling, and bioinformatics database
US6673554B1 (en) 1999-06-14 2004-01-06 Trellie Bioinformatics, Inc. Protein localization assays for toxicity and antidotes thereto
US20040225449A1 (en) * 1999-06-28 2004-11-11 Bevilacqua Michael P. Systems and methods for characterizing a biological condition or agent using selected gene expression profiles
US7049132B1 (en) 1999-06-28 2006-05-23 University Of Southern California Stress-responsive induction of a therapeutic agent and methods of use
HK1044568A1 (zh) * 1999-06-28 2002-10-25 University Of Southern California 一种治疗剂的应激应答性诱导及其使用方法
US20050060101A1 (en) * 1999-06-28 2005-03-17 Bevilacqua Michael P. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
US20060115826A1 (en) * 1999-06-28 2006-06-01 Michael Bevilacqua Gene expression profiling for identification monitoring and treatment of multiple sclerosis
US20080183395A1 (en) * 1999-06-28 2008-07-31 Michael Bevilacqua Gene expression profiling for identification, monitoring and treatment of multiple sclerosis
US6692916B2 (en) * 1999-06-28 2004-02-17 Source Precision Medicine, Inc. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
US6960439B2 (en) 1999-06-28 2005-11-01 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
US6931396B1 (en) 1999-06-29 2005-08-16 Gene Logic Inc. Biological data processing
US20020087511A1 (en) * 1999-09-02 2002-07-04 Johnson Peter C. Methods for profiling and manufacturing tissue using a database that includes indices representative of a tissue population
US6727100B1 (en) * 1999-10-21 2004-04-27 4Sc Ag Method of identifying candidate molecules
GB2355791B (en) * 1999-10-28 2004-10-20 Molecular Light Tech Res Ltd Detection of mRNA expression using chemiluminescent labelled probes
EP1130086A1 (de) * 2000-02-18 2001-09-05 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Genetische manipulierte Keratinozyten und deren Verwendung zur Prüfung der Toxizität
US20040115627A1 (en) * 2000-04-12 2004-06-17 Judy Raucy Compositions and methods for induction of proteins involved in xenobiotic metabolism
US6696239B1 (en) 2000-04-20 2004-02-24 Biolog, Inc. Comparative phenotype analysis for assessment of biological active compounds such as antimicrobials
JP2004523201A (ja) * 2000-05-16 2004-08-05 ザ チルドレンズ マーシー ホスピタル シングルコピーゲノムのハイブリダイゼーションプローブおよびその作製方法
US6828097B1 (en) * 2000-05-16 2004-12-07 The Childrens Mercy Hospital Single copy genomic hybridization probes and method of generating same
US7020561B1 (en) 2000-05-23 2006-03-28 Gene Logic, Inc. Methods and systems for efficient comparison, identification, processing, and importing of gene expression data
US6902882B2 (en) 2000-05-23 2005-06-07 Kerong Gu Methods of monitoring production of gene products and uses thereof
US20030171876A1 (en) * 2002-03-05 2003-09-11 Victor Markowitz System and method for managing gene expression data
KR100865664B1 (ko) * 2000-06-14 2008-10-29 비스타겐 인코포레이티드 간 줄기 세포를 사용하는 독성 타이핑
WO2002006834A2 (en) * 2000-07-19 2002-01-24 Pointilliste, Inc. Nested sorting and high throughput screening
WO2002008453A2 (en) * 2000-07-21 2002-01-31 Phase-1 Molecular Toxicology Canine toxicity genes
US7613571B2 (en) * 2000-07-28 2009-11-03 Doyle Michael D Method and system for the multidimensional morphological reconstruction of genome expression activity
US7590493B2 (en) * 2000-07-31 2009-09-15 Ocimum Biosolutions, Inc. Methods for determining hepatotoxins
CA2414421A1 (en) * 2000-07-31 2002-02-07 Gene Logic, Inc. Molecular toxicology modeling
CA2327581A1 (en) * 2000-12-27 2002-06-27 Yves Blais Methods and compositions for the establishment of genetically altered cell-based library designed for monitoring transcriptional activity of compounds and molecules
AU2002237879A1 (en) * 2001-01-23 2002-08-06 Gene Logic, Inc. A method and system for predicting the biological activity, including toxicology and toxicity, of substances
AU2002230372B2 (en) * 2001-02-05 2008-03-13 Shen Quan Pan Methods and kits for identifying scavengers of reactive oxygen species (ROS)
JP2004524843A (ja) * 2001-02-23 2004-08-19 イーラン ファーマスーティカルズ、インコーポレイテッド Ｂａｃｅ−１のトランスジェニックノックアウト
WO2002073504A1 (en) * 2001-03-14 2002-09-19 Gene Logic, Inc. A system and method for retrieving and using gene expression data from multiple sources
US20020159625A1 (en) * 2001-04-02 2002-10-31 Cytoprint, Inc. Method and apparatus for discovering, identifying and comparing biological activity mechanisms
US20070015146A1 (en) * 2001-05-22 2007-01-18 Gene Logic, Inc. Molecular nephrotoxicology modeling
CA2447357A1 (en) 2001-05-22 2002-11-28 Gene Logic, Inc. Molecular toxicology modeling
US20070054269A1 (en) * 2001-07-10 2007-03-08 Mendrick Donna L Molecular cardiotoxicology modeling
AU2002365904A1 (en) * 2001-07-10 2003-09-04 Gene Logic, Inc. Cardiotoxin molecular toxicology modeling
US7447594B2 (en) 2001-07-10 2008-11-04 Ocimum Biosolutions, Inc. Molecular cardiotoxicology modeling
US20030143612A1 (en) * 2001-07-18 2003-07-31 Pointilliste, Inc. Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening
US7251642B1 (en) 2001-08-06 2007-07-31 Gene Logic Inc. Analysis engine and work space manager for use with gene expression data
EP1427850A4 (de) * 2001-08-16 2006-02-08 Phase 1 Molecular Toxicology I Toxikologisch relevante menschliche gene und arrays
WO2003018839A1 (en) * 2001-08-23 2003-03-06 University College Dublin, National University Of Ireland, Dublin Identification of a common promoter module in disease associated genes
JP2003079365A (ja) 2001-09-07 2003-03-18 Kanegafuchi Chem Ind Co Ltd 環境有害化学物質の高感度検出法
US7842498B2 (en) 2001-11-08 2010-11-30 Bio-Rad Laboratories, Inc. Hydrophobic surface chip
US6964850B2 (en) * 2001-11-09 2005-11-15 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
WO2003062402A2 (en) * 2002-01-24 2003-07-31 Pointilliste, Inc. Use of collections of binding sites for sample profiling and other applications
AU2003210820B2 (en) 2002-01-31 2007-12-20 University Of Rochester Light activated gene transduction using ultraviolet light for cell targeted gene delivery
CA2471661A1 (en) * 2002-01-31 2003-08-07 Gene Logic, Inc. Molecular hepatotoxicology modeling
US7704272B2 (en) 2002-01-31 2010-04-27 University Of Rochester Method for introducing an ultraviolet light activated viral vector into the spinal column
US7469185B2 (en) * 2002-02-04 2008-12-23 Ocimum Biosolutions, Inc. Primary rat hepatocyte toxicity modeling
CA2486105A1 (en) * 2002-05-17 2004-04-29 Baylor College Of Medicine Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemoresistance
ITTO20020729A1 (it) * 2002-08-14 2004-02-15 Consorzio Interuniversitario Per Le Biotecnologie Cellule di mammifero non umano geneticamente modificate, procedimento per la loro produzione e utilizzo in test di tossicita'.
US20050042623A1 (en) * 2002-10-30 2005-02-24 Dana Ault-Riche Systems for capture and analysis of biological particles and methods using the systems
WO2004071641A2 (en) * 2003-02-10 2004-08-26 Pointilliste, Inc. Self-assembling arrays and uses thereof
US7853406B2 (en) 2003-06-13 2010-12-14 Entelos, Inc. Predictive toxicology for biological systems
CA2445420A1 (en) 2003-07-29 2005-01-29 Invitrogen Corporation Kinase and phosphatase assays
US7727752B2 (en) 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
US7619059B2 (en) 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
WO2005014793A2 (en) * 2003-08-07 2005-02-17 Gene Logic, Inc. Primary rat hepatocyte toxicity modeling
WO2005045426A2 (en) * 2003-11-10 2005-05-19 Aic Gene expression profiling of hazardous compounds and corresponding database clustering algorithm
US20080281526A1 (en) * 2004-03-22 2008-11-13 Diggans James C Methods For Molecular Toxicology Modeling
JP2007533005A (ja) * 2004-04-07 2007-11-15 ジーン ロジック インコーポレイテッド 肝毒性分子モデル
GB0410105D0 (en) * 2004-05-06 2004-06-09 Amersham Biosciences Uk Ltd Method for characterising compounds
WO2006017559A1 (en) * 2004-08-02 2006-02-16 University Of Iowa Research Foundation Methods of inhibiting manganese-containing superoxide dismutase 2 (mnsod)
US7646450B2 (en) * 2005-12-29 2010-01-12 Lg Display Co., Ltd. Light emitting diode array, method of manufacturing the same, backlight assembly having the same, and LCD having the same
US20070218456A1 (en) * 2006-02-08 2007-09-20 Invitrogen Corporation Cellular assays for signaling receptors
AU2007305166A1 (en) * 2006-10-03 2008-04-10 University Of Southern California GRP78 as a predictor of responsiveness to therapeutic agents
MX2010003371A (es) * 2007-09-28 2010-05-05 Intrexon Corp Constructos interruptores genicos terapeuticos y biorreactores para la expresion de moleculas bioterapeuticas y usos de los mismos.
RU2573912C2 (ru) 2008-10-08 2016-01-27 Интрексон Корпорейшн Сконструированные клетки, экспрессирующие множественные иммуномодуляторы, и их применения
EP2199794A1 (de) 2008-12-17 2010-06-23 Universiteit Maastricht Verfahren zur Identifizierung von krebserregenden Verbindungen
EP2694687B1 (de) * 2011-04-08 2018-01-31 Anthem Biosciences Pvt Ltd In-vitro-verfahren zum screening genotoxischer mittel in eukaryotischen zellen mit hohem durchsatz
EP2748338B1 (de) * 2011-09-08 2017-04-26 Attagene, Inc. Systeme und verfahren für ein assay aus biokontaminantien in wasser
WO2019070704A1 (en) * 2017-10-02 2019-04-11 Georgia Tech Research Corporation METHODS AND COMPOSITIONS FOR ENGINEERING SYNTHESIS BIOLOGICAL SWITCHES FOR REMOTE CONTROL OF BIOLOGICAL ACTIVITY
WO2019157421A1 (en) 2018-02-09 2019-08-15 W. L. Gore & Associates, Inc. Implantable access chamber and associated methods of use
EP4069731A4 (de) 2019-12-03 2024-05-29 Alamar Biosciences, Inc. Nukleinsäure-gekoppelter immun-sandwich-assay (nulisa)
KR102382748B1 (ko) * 2020-07-28 2022-04-05 가톨릭대학교 산학협력단 Egr1 프로모터 영역을 포함하는 재조합 벡터 및 이의 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533584B1 (fr) * 1982-09-28 1986-03-21 Pasteur Institut Procede de detection du pouvoir mutagene de substances, susceptibles d'induire la deterioration d'adn cellulaires, mettant en jeu la production d'une reponse sos
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
US4997757A (en) * 1987-12-23 1991-03-05 Genebiomed, Inc. Process for detecting potential carcinogens
NL8801826A (nl) * 1988-07-19 1990-02-16 Tno Werkwijze voor het detecteren van mutaties in markergenen.
US5232833A (en) * 1988-09-14 1993-08-03 Stressgen Biotechnologies Corporation Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
GB8905394D0 (en) * 1989-03-09 1989-04-19 Delta Biotechnology Ltd Detection of certain molecules
US5149634A (en) * 1989-04-14 1992-09-22 The University Of Maryland Bioassay for environmental quality
US5665543A (en) * 1989-07-18 1997-09-09 Oncogene Science, Inc. Method of discovering chemicals capable of functioning as gene expression modulators
AU660405B2 (en) † 1989-07-18 1995-06-29 Osi Pharmaceuticals, Inc. Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators
JPH04506750A (ja) † 1989-07-18 1992-11-26 オンコジーン・サイエンス・インコーポレイテッド 自動化実験室装置
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
FI931268L (fi) * 1990-09-24 1993-04-21 Gen Hospital Corp Saollningsfoerfaranden
WO1992011033A1 (en) * 1990-12-20 1992-07-09 Arch Development Corporation Control of gene expression by ionizing radiation
NL9100567A (nl) * 1991-04-02 1992-11-02 Ingeny Bv Werkwijze voor het detecteren van mutaties, transgeen zoogdier, transgene zoogdiercel, en werkwijze voor het onderzoeken van stoffen of omstandigheden op mutagene eigenschappen.
EP0516443A1 (de) * 1991-05-31 1992-12-02 Eli Lilly And Company Vektoren und Verfahren um die Regulation von Apolipoprotein-AI-Synthese zu Testen
KR100300932B1 (ko) * 1992-07-06 2001-10-22 조이스 브린톤 리포터유전자에융합된세균의스트레스프로모터를이용하여독성을측정하는방법및진단키트
HK1004920A1 (en) * 1993-01-21 1998-12-11 President And Fellows Of Harvard College Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound

Also Published As

Publication number Publication date
EP0680517A1 (de) 1995-11-08
US5811231A (en) 1998-09-22
DE69406772D1 (de) 1997-12-18
EP0680517B1 (de) 1997-11-12
ES2111289T3 (es) 1998-03-01
US20030219714A1 (en) 2003-11-27
JPH09503121A (ja) 1997-03-31
ES2111289T5 (es) 2005-07-16
CA2154265C (en) 2011-01-04
DK0680517T3 (da) 1998-07-27
AU6124394A (en) 1994-08-15
EP0680517B2 (de) 2005-01-19
CA2154265A1 (en) 1994-08-04
DE69406772T2 (de) 1998-03-12
DK0680517T4 (da) 2005-05-02
JP3509100B2 (ja) 2004-03-22
US20030027127A1 (en) 2003-02-06
WO1994017208A1 (en) 1994-08-04
AU692434B2 (en) 1998-06-11
DE69406772T3 (de) 2005-11-17
GR3026129T3 (en) 1998-05-29
HK1004920A1 (en) 1998-12-11

Similar Documents

Publication Publication Date Title
ATE160178T1 (de) Verfahren und diagnostische kits unter verwendung von säuger-stresspromotoren zur bestimmung der toxizität einer verbindung
DE69316368D1 (de) Verfahren und diagnostische kits zur bestimmung der toxizität einer verbindung unter verwendung von an bakterielle stresspromotoren fusionierten reportergenen
FI925986A0 (fi) Slumpartat bio-oligomer bibliotek, ett foerfarande foer syntetisering avdet samt ett foerfarande foer anvaendning av det
DE69638162D1 (de) Bindegewebs wachstumsfaktor (ctgf)
RU95115239A (ru) Аналог эритропоэтина
DE69738739D1 (de) Verfahren für das Entwerfen von kleinen Erythropoietin Mimetika
BR0013231A (pt) Complexos citocina-anticorpo múltiplos
ES2127831T3 (es) Unidades de expresion multicistronicas y su aplicacion.
ES2130177T3 (es) Tratamiento de poblaciones de celulas.
EA200000325A1 (ru) Способ доставки генов в антиген-презентирующие клетки кожи
DE69824597D1 (de) Ikk-beta proteine, nukleinsäuren und verfahren
ATE287962T1 (de) Rekombinante zelle, dna-konstruktionen, vektoren und methoden zur expression von phytatabbauenden enzymen in gewünschten verhältnissen
PT979308E (pt) Metodo de preparacao de um padrao tipo de um transcrito genetico para diagnostico
NO982794D0 (no) Diagnostisering og behandling av AUR-1 og/eller AUR-2 relaterte lidelser
Gonzalez-Hernandez et al. Sox17 controls emergence and remodeling of nestin-expressing coronary vessels
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
EP0947583A3 (de) Expressionsaktivierende Nukleinsäurefragmente des Melanom-inhibierenden Proteins (MIA)
DE69737062D1 (de) Gentherapie für kongestives herzversagen
ATE251886T1 (de) Verwendunf von apoe zum binden von tau und map2c proteinen und zur behandlung von alzheimer's krankheit
ATE508201T1 (de) Verfahren zur generierung eines gentechnisch veränderten organismus für das wirksubstanzscreening
EP0922768A3 (de) Onkogen- oder virusgesteuerte Expressionssysteme
DE69402961D1 (de) Verfahren zum Nachweis von viralen Komponenten mittels eines Glykoproteins
DE3861597D1 (de) Verwendung von polyharnstoff-modifizierten polyetherurethanen als emulsionsspalter fuer wasser-in-oel-emulsionen.
Hiroi et al. Involvement of gicerin, a cell adhesion molecule, in development and regeneration of chick sciatic nerve
BR9712128A (pt) Métodos e composições para lipidização de moléculas hidrofìlicas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties